| Issue Date | Title | Author(s) |
| Feb-2021 | College of American Pathologists Tumor Regression Grading System for Long-term Outcome in Patients with Locally Advanced Rectal Cancer | Chen, Hai-Yang; Feng, Li-Li; Li, Ming; Ju, Huai-Qiang; Ding, Yi; Lan, Mei; Song, Shu-Mei; Han, Wei-Dong; Yu, Li; Wei, Ming-Biao; Pang, Xiao-Lin; He, Fang; Liu, Shuai; Zheng, Jian; Ma, Yan; Lin, Chu-Yang; Lan, Ping; Huang, Mei-Jin; Zou, Yi-Feng; Yang, Zu-Li; Wang, Ting; Lang, Jin-Yi; Orangio, Guy R.; Poylin, Vitaliy; Ajani, Jaffer A.; Wang, Wei-Hu; Wan, Xiang-Bo |
| 2013 | Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study | Ohtsu, Atsushi; Ajani, Jaffer A.; Bai, Yu-Xian; Bang, Yung-Jue; Chung, Hyun-Cheol; Pan, Hong-Ming; Sahmoud, Tarek; Shen, Lin; Yeh, Kun-Huei; Chin, Keisho; Muro, Kei; Kim, Yeul Hong; Ferry, David; Tebbutt, Niall C.; Al-Batran, Salah-Eddin; Smith, Heind; Costantini, Chiara; Rizvi, Syed; Lebwohl, David; Van Cutsem, Eric |
| 15-Jun-2022 | Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): CheckMate 649 biomarker analyses | Lei, Ming; Janjigian, Yelena Y.; Ajani, Jaffer A.; Moehler, Markus; Wang, Xuya; Shen, Lin; Garrido, Marcelo; Gallardo, Carlos; Yamaguchi, Kensei; Wyrwicz, Lucjan; Skoczylas, Tomasz; Bragagnoli, Arinilda; Liu, Tianshu; Tehfe, Mustapha; Elimova, Elena; Li, Mingshun; Poulart, Valerie; Wang, Yu; Doshi, Parul; Shitara., Kohei |
| 2012 | Safety of everolimus (EVE) in Asian patients (pts) with advanced gastric cancer (AGC) enrolled in the phase III GRANITE-1 study | Yeh, Kun-Huei; Van Cutsem, Eric; Ohtsu, Atsushi; Shen, Lin; Ajani, Jaffer A.; Rizvi, Syed; Sedova, Michaela; Costantini, Chiara; Smith, Heind; Sahmoud, Tarek; Bang, Yung-Jue |
| 1-Feb-2022 | Tislelizumab versus chemotherapy as second-line treatment for advanced or metastatic esophageal squamous cell carcinoma (ESCC, RATIONALE 302): Impact on health-related quality of life (HRQoL) | Van Cutsem, Eric; Kato, Ken; Ajani, Jaffer A.; Shen, Lin; Xia, Tianyu; Ding, Ningning; Zhan, Lin; Barnes, Gisoo; Kim, Sung-Bae |
| 10-Sep-2022 | Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study | Shen, Lin; Kato, Ken; Kim, Sung-Bae; Ajani, Jaffer A.; Zhao, Kuaile; He, Zhiyong; Yu, Xinmin; Shu, Yongqian; Luo, Qi; Wang, Jufeng; Chen, Zhendong; Niu, Zuoxing; Zhang, Longzhen; Yi, Tienan; Sun, Jong-Mu; Chen, Jianhua; Yu, Guohua; Lin, Chen-Yuan; Hara, Hiroki; Bi, Qing; Satoh, Taroh; Pazo-Cid, Roberto; Arkenau, Hendrick-Tobias; Borg, Christophe; Lordick, Florian; Li, Liyun; Ding, Ningning; Tao, Aiyang; Shi, Jingwen; Van Cutsem, Eric |
| Jan-2021 | YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition | Ajani, Jaffer A.; Xu, Yan; Huo, Longfei; Wang, Ruiping; Li, Yuan; Wang, Ying; Pizzi, Melissa Pool; Scott, Ailing; Harada, Kazuto; Ma, Lang; Yao, Xiaodan; Jin, Jiankang; Zhao, Wei; Dong, Xiaochuan; Badgwell, Brian D.; Shanbhag, Namita; Tatlonghari, Ghia; Estrella, Jeannelyn Santiano; Roy-Chowdhuri, Sinchita; Kobayashi, Makoto; Vykoukal, Jody V.; Hanash, Samir M.; Calin, George Adrian; Peng, Guang; Lee, Ju-Seog; Johnson, Randy L.; Wang, Zhenning; Wang, Linghua; Song, Shumei |
